Projects funded by the NCN

Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

1340 projects found matching your search criteria :

  1. Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

    Call: SONATA BIS 13 , Panel: NZ7

    Principal investigator: dr hab. Miłosz Ruszkowski

    Instytut Chemii Bioorganicznej PAN

  2. Exploring kinase hyperactivation as an innovative approach for chemo-immunotherapy for B cell acute lymphoblastic leukem...

    Call: PRELUDIUM BIS 5 , Panel: NZ7

    Principal investigator: dr hab. Małgorzata Firczuk

    Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

  3. Macrocyclic peptides for targeting of membrane-anchored serine protease

    Call: PRELUDIUM BIS 5 , Panel: NZ7

    Principal investigator: dr hab. Paulina Maria Kasperkiewicz-Wasilewska

    Politechnika Wrocławska

  4. A new generation of scaffolds based on curdlan and whey protein isolate obtained by electrospinning for the treatment of...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Katarzyna Klimek

    Uniwersytet Medyczny w Lublinie

  5. Functional and structural analysis of anticancer drugs as protein biosynthesis inhibitors

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr hab. Witold Szaflarski

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

  6. Spatiotemporal control of growth factor release from porous composite scaffolds for chronic wound healing.

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Tomasz Marek Urbaniak

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  7. "One step to game changer": combined antimicrobial therapy based on AI and nanotechnology to combat challenging diabetes...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Barbara Ewa Pucelik

    Sieć Badawcza ŁUKASIEWICZ - Krakowski Instytut Technologiczny

  8. Restoring Beta-cell Integrity through Targeted SPOP Inhibition and PDX-1 Preservation

    Call: OPUS 26 (LAP) , Panel: NZ7

    Principal investigator: dr Anna Czarna

    Uniwersytet Jagielloński, Małopolskie Centrum Biotechnologii Uniwersytetu Jagiellońskiego

  9. Light-induced photoreceptor morphological changes – Towards objective and impartial diagnostics in ophthalmology

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Humberto Couto Fernandes

    Instytut Chemii Fizycznej Polskiej Akademii Nauk, Międzynarodowe Centrum Badań Oka

  10. CAR(dio)-T(oxicity)- Engineered Heart Tissue model for CAR-T cardiotoxicity evaluation

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Agnieszka Joanna Zimna

    Instytut Genetyki Człowieka PAN

  11. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

    Call: OPUS 26 , Panel: NZ7

    Principal investigator: dr Agnieszka Wnuk

    Instytut Farmakologii PAN

  12. Genomic analysis of invasive vancomycin-resistant Enterococcus faecium of VanA phenotype from intensive-care units in Po...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Ewa Nina Wardal

    Narodowy Instytut Leków

  13. Selective inhibition of Janus kinases for the treatment of autoimmune hepatitis: Translational PK/PD modelling from mole...

    Call: SONATA 19 , Panel: NZ7

    Principal investigator: dr Artur Świerczek

    Uniwersytet Jagielloński, Collegium Medicum

  14. REMIND HF - Evaluation of REmote Motivational INterviewing for Disease management in Heart Failure patients and their ca...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: prof. Izabella Uchmanowicz

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  15. Using DNA methylation markers and epigenetic clocks as an innovative tool to assess health, risk indicators, and manage ...

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Ewelina Maria Pośpiech

    Pomorski Uniwersytet Medyczny w Szczecinie

  16. Synthesis of novel hybrid nanomaterials based on fullerene scaffold for photodynamic therapy of cancer

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Dominik Jakub Dreszer

    UNIWERSYTET ŚLĄSKI

  17. Anti-neuroinflammatory and antidepressant activities of mycelial in vitro cultures of selected edible mushrooms enriched...

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Jan Patryk Lazur

    Uniwersytet Jagielloński

  18. Modulation of the Gut Microbiome as a Strategy to Counteract Hormone-Dependent Disorders

    Call: OPUS 27 , Panel: NZ7

    Principal investigator: dr hab. Tomasz Janeczko

    Uniwersytet Przyrodniczy we Wrocławiu

  19. Biomaterial enriched with propolis extract as a promising chemopreventive dressing material after melanoma excision

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Marta Trzaskowska

    Uniwersytet Medyczny w Lublinie

  20. Phage-Antimicrobial combination Strategies for management of multidrug-resistant E. coli and K. pneumoniae

    Call: JPIAMR ACTION Call 2024 , Panel: NZ7

    Principal investigator: prof. Krystyna Dąbrowska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  21. Biological activity of AmB: Are the dynamics of interaction with the cell membrane the key?

    Call: PRELUDIUM 23 , Panel: NZ7

    Principal investigator: Sebastian Janik

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie

  22. Harnessing NK cells and Graphene Oxide Nanoparticles for Pancreatic Ductal Adenocarcinoma Immunotherapy

    Call: OPUS 28 (LAP) , Panel: NZ7

    Principal investigator: prof. Iwona Maria Inkielewicz-Stępniak

    Gdański Uniwersytet Medyczny

  23. "Integrated Fixed-Dose Combination Drugs in Depression Therapy: A New Standard of Treatment and Mechanism of Action Stud...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Gabriel Piotr Nowak

    Instytut Farmakologii PAN

  24. Identification of biomarkers to understand the pathogenesis of Obstructive Sleep Apnea.

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: prof. Ewa Olszewska

    Uniwersytet Medyczny w Białymstoku

  25. Cannabidiol as a Neuroprotective Therapy: Are Brain Regeneration Mechanisms After Perinatal Hypoxia-Ischemia Sex-Depende...

    Call: SONATA 20 , Panel: NZ7

    Principal investigator: dr Hanna Kletkiewicz

    Uniwersytet Mikołaja Kopernika

  26. Defining The Role of Microbiome Mimicry in Type 1 Diabetes (T1D): a pilot study for Single-Cell Strain-characterisation ...

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Marcin Lukasz Pekalski

    Wojskowy Instytut Medyczny

  27. Targeting Telomere Integrity as an Approach to Eradicate Cancer Cells

    Call: OPUS 28 , Panel: NZ7

    Principal investigator: dr Natalia Anna Maciejewska

    Politechnika Gdańska

  28. Role of the sinonasal microbiota in modulating airway immunity and allergic inflammation

    Call: OPUS 28 (LAP) , Panel: NZ7

    Principal investigator: dr hab. Sabina Barbara Górska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  29. Advanced High-Throughput Microfluidic Platform for Engineered T-Cell Screening

    Call: SONATINA 9 , Panel: NZ7

    Principal investigator: dr Alicja Andrea Przybyszewska-Podstawka

    Uniwersytet Warszawski

  30. NMR Spectroscopy as Molecular Language: A Deep Learning Approach to Bioactivity Prediction

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Arkadiusz Bogumił Leniak

    Instytut Farmakologii PAN

  31. Structural and Biocompatibility Aspects of Duo-gels: Fundamental Research on the Integration of Hydrophobic and Hydrophi...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Alicja Przybyłowicz

    Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

  32. Building cognitive and brain reserve: the trajectory of protective and risk factors in a longitudinal cohort study of th...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Katarzyna Zatońska

    Uniwersytet Medyczny im. Piastów Śląskich we Wrocławiu, Wydział Farmaceutyczny z Oddziałem Analiutyki Medycznej

  33. Mini-tumors, big answers: Modeling of immune system's activation with organoid-based PDT-on-Chip technology

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Marta Karolina Warszyńska

    Uniwersytet Jagielloński

  34. Targeting endothelial cell senescence in diabetic retinopathy with rapamycin-loaded nanoparticles

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Gabriela Burda

    Uniwersytet Jagielloński

  35. Multifunctional polymer-based scaffold incorporating green synthesized nanocomposite and silibinin for liver regeneratio...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Barbara Agnieszka Strojny-Cieślak

    Szkoła Główna Gospodarstwa Wiejskiego w Warszawie

  36. Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Alicja Stanisława Słota

    Uniwersytet Jagielloński

  37. CTC-on-CAM: a platform for studying heterogeneity, epithelial-mesenchymal transition, and therapeutic sensitivity of cir...

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: prof. Marek Arkadiusz Murias

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

  38. Strategy to overcome the "ionic checkpoint" and improve the antitumor immunotherapy.

    Call: OPUS 29 , Panel: NZ7

    Principal investigator: dr Beata Pyrzyńska

    Warszawski Uniwersytet Medyczny

  39. Role of the BRM- ERα interaction in the conferring of resistance to paclitaxel in BRG1-deficient cancers

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Karolina Gronkowska

    Uniwersytet Łódzki

  40. Kombucha as a potential support in insulin resistance: a multilevel analysis of the biological activity of kombucha from...

    Call: PRELUDIUM 24 , Panel: NZ7

    Principal investigator: Klaudia Melkis

    Pomorski Uniwersytet Medyczny w Szczecinie

O Narodowym Centrum Nauki

Finansowanie nauki

Współpraca zagraniczna

Centrum prasowe

Deklaracja dostępności
Przetwarzanie danych osobowych
Polityka cookies

Partnerzy